OBJECTIVES: We describe age-specific survival in thyroid cancer (TC) from Denmark, Finland, Norway, and Sweden over a 50-year period. DESIGN: Population-based survival study. METHODS: Relative 5-year survival data were obtained from the NORDCAN database for the years 1972-2021. RESULTS: In the first period 1972-1976, 5-year survival in TC in Finland, Norway, and Sweden was 90% or higher, but a strong negative step-wise age gradient was observed, which was worse for men than women. Over time, survival increased, and in the final period, 2017-2021, survival for all women and Danish men up to age 69 years was about 90% or higher and, for men from the other countries, only marginally lower. Even for older women survival reached 80%, for older men somewhat less. CONCLUSIONS: Age disadvantage in TC survival was for the most part corrected over the 50-year period, and the remaining task is to boost survival for the oldest patients.
- MeSH
- incidence MeSH
- lidé MeSH
- míra přežití MeSH
- nádory štítné žlázy * terapie MeSH
- registrace MeSH
- rizikové faktory MeSH
- senioři MeSH
- věkové rozložení MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Dánsko MeSH
- Finsko MeSH
- Norsko MeSH
- Skandinávie a severské státy MeSH
- Švédsko MeSH
- Klíčová slova
- mast Abilar,
- MeSH
- hojení ran účinky léků MeSH
- lidé MeSH
- masti terapeutické užití MeSH
- rány a poranění * farmakoterapie MeSH
- rostlinné pryskyřice * analýza terapeutické užití MeSH
- smrk mikrobiologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- novinové články MeSH
- rozhovory MeSH
- Geografické názvy
- Finsko MeSH
OBJECTIVES: We analyze survival in thyroid cancer from Denmark (DK), Finland (FI), Norway (NO), and Sweden (SE) over a 50-year period (1971-2020), and additionally consider concomitant changes in incidence and mortality. DESIGN: Population-based survival study. METHODS: Relative 1-, 5/1 (conditional)-, and 5-year survival data were obtained from the NORDCAN database for years 1971-2020. Incidence and mortality rates were also assessed. RESULTS: A novel consistent observation was that 1-year survival was worse than 5/1-year survival but the difference between these decreased with time. Relative 1-year survival in thyroid cancer (mean for the 4 countries) reached 92.7% for men and 95.6% for women; 5-year survival reached 88.0% for men and 93.7% for women. Survival increased most for DK which started at a low level and reached the best survival at the end. Male and female incidence rates for thyroid cancer increased 3- and 4-fold, respectively. In the same time, mortality halved for men and for women, it decreased by 2/3. CONCLUSIONS: We documented worse relative survival in the first year than in the 4 subsequent years, most likely because of rare anaplastic cancer. Overall survival in thyroid cancer patients increased in the Nordic countries in the course of 50 years; 5-year survival was close to 90% for men and close to 95% for women. Even though overdiagnosis may explain some of 5-year survival increase, it is unlikely to influence the substantial increase in 1-year survival. The unmet need is to increase 1-year survival by diagnosing and treating aggressive tumors before metastatic spread.
- MeSH
- databáze faktografické MeSH
- lidé MeSH
- nádory štítné žlázy * diagnóza epidemiologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Finsko MeSH
- Norsko MeSH
PURPOSE: Sarcomas are rare cancers with many subtypes in soft tissues, bone and cartilage. International survival trends in these cancers are not well known. We present 50-year survival trends for soft tissue sarcoma (STS) and bone sarcoma (BS) in Denmark (DK), Finland (FI), Norway (NO) and Sweden (SE). METHODS: Relative 1-, 5/1 conditional- and 5-year survival data were obtained from the NORDCAN database for years 1971-20. We additionally estimated annual changes in survival rates and determined significant break points. RESULTS: In the last period, 2016-20, 5-year survival in STS was best for NO men (74.6%) and FI women (71.1%). For the rarer BS, survival rates for SE men (72.0%) and DK women (71.1%) were best. Survival in BS was lower than that in STS in 1971-75 and the difference remained in 2016-20 for men, but for women the rates were almost equal. Sex- and country-specific differences in survival in STS were small. The 50-year improvement in 5-year survival in STS was highest in NO men, 34.0 % units and FI women, 30.0 % units. The highest improvements in BS were in SE men 26.2 % units and in FI women 29.2 % units. CONCLUSIONS: The steady development in survival over the half century suggests contribution by stepwise improvements in diagnostics, treatment and care. The 10-15% mortality in the first year probably indicates diagnostic delays which could be improved by organizing patient pathways for aggressive rare diseases. Early diagnosis would also reduce metastatic disease and breakthroughs in treatment are a current challenge.
- MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nádory kostí * mortalita epidemiologie patologie MeSH
- nádory měkkých tkání mortalita epidemiologie patologie MeSH
- osteosarkom mortalita epidemiologie patologie terapie MeSH
- registrace MeSH
- sarkom * mortalita epidemiologie patologie terapie MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Finsko MeSH
- Skandinávie a severské státy MeSH
BACKGROUND: Survival in breast cancer (BC) has developed favorably but late recurrences are still a problem. METHODS: We model survival data from the NORDCAN database and analyze 1-, 5-, and 10-year relative survival and 5/1- and 10/5-year conditional survival in BC from Denmark (DK), Finland (FI), Norway (NO), and Sweden (SE) between 1971 and 2020. Conditional survival measures survival in those who had survived year 1 to reach year 5 (5/1), or in those who had survived year 5 to reach year 10 (10/5). RESULTS: Almost all survival metrics were best for SE but survival in all countries improved in the course of time approaching the SE levels which were 98.3% for 1-year, 92.3% for 5-year, and 87.8% for 10-year survival. Conditional 10/5-year survival, covering 5 years, was better than 5/1-year survival, covering 4 years. A contributing factor is most likely the high rate of recurrence in period 2-5 years. The difference was observed for all countries but for DK 10/5-year survival approached 1-year survival and for NO and SE 10/5-year survival was only barely better than 5/1-year survival. The explanation to this was the excellent 10/5-year survival in DK compared to SE and particularly to NO. Literature search suggested that the reason for the relatively low 10/5-year survival in NO might be stagnant survival development in old patients. CONCLUSIONS: We assume that late mortality is critically limiting survival in BC and either interference with the late metastatic process or effective treatment will be key to future improvements in BC survival.
- MeSH
- lidé MeSH
- míra přežití MeSH
- nádory prsu * epidemiologie terapie MeSH
- registrace MeSH
- rizikové faktory MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Dánsko MeSH
- Finsko MeSH
- Norsko MeSH
- Skandinávie a severské státy MeSH
- Švédsko MeSH
Background and Purpose: Currently, there is no available Finnish version of the Genomic Nursing Concept Inventory tool (GNCI). This study tested the validity, reliability, and clinical usability of a Finnish translation. Methods: A decision tree algorithm was used to guide the translation, as per International Society for Pharmacoeconomics and Outcomes Research guidelines. Item-Content Validity Index (I-CVI), modified kappa (k*) statistics, and Cronbach's alpha were calculated. Results: The I-CVI and k* values were "good" to "excellent" (I-CVI = 0.63-1.00, k* = 0.52-1.00), and Cronbach's alpha value was "good" (α = 0.816; 95% confidence interval: 0.567-0.956). Conclusion: The Mandysova's decision tree algorithm provided clear and rigorous direction for the translation and validity of the Finnish GNCI.
- MeSH
- genomika * MeSH
- lidé MeSH
- lingvistika * MeSH
- průzkumy a dotazníky MeSH
- reprodukovatelnost výsledků MeSH
- rozhodovací stromy MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Finsko MeSH
Aim: The aim of this study was to describe the three main competencies that every healthcare professional working within palliative care should have, according to the perspective of another professional body working within palliative care. Design: A descriptive qualitative study. Methods: The data were collected from physicians, registered nurses, licensed practical nurses and professional stakeholders by means of an electronic survey in 2018. The data were analyzed using content analysis. Results: The three most important competencies of every healthcare professional working within palliative care were considered to be advance care planning; symptom management; and communication and psychosocial support for patients and their significant others. Advance care planning and symptom management were the main competencies expected from physicians. Symptom management and communication, psychosocial and existential support for patients and their significant others were the main competencies expected from nurses and practical nurses. Conclusion: The findings can be utilized in the education of palliative nursing and medicine to ensure a palliative approach and symptom management in an adequate time frame as well as communication and psychosocial and existential support. The findings offer clues for understanding the roles of the multi-professional team and for competence development through multi-professional continuing education within palliative care.
- MeSH
- lidé MeSH
- odborná způsobilost * statistika a číselné údaje MeSH
- paliativní péče * MeSH
- postoj zdravotnického personálu MeSH
- průzkumy a dotazníky MeSH
- zdravotní sestry MeSH
- zdravotnický personál MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
- Geografické názvy
- Finsko MeSH
Cyberhate is one of the online risks that adolescents can experience online. It is considered a content risk when it is unintentionally encountered and a conduct risk when the user actively searches for it. Previous research has not differentiated between these experiences, although they can concern different groups of adolescents and be connected to distinctive risk factors. To address this, our study first focuses on both unintentional and intentional exposure and investigates the individual-level risk factors that differentiate them. Second, we compare each exposed group of adolescents with those who were not exposed to cyberhate. We used survey data from a representative sample of adolescents (N = 6,033, aged 12-16 years, 50.3 percent girls) from eight European countries-Czechia, Finland, Flanders, France, Italy, Poland, Romania, and Slovakia-and conducted multinomial logistic regression. Our findings show that adolescents with higher sensation seeking, proactive normative beliefs about aggression (NBA), and who report cyberhate perpetration, are at higher risk of intentionally searching for cyberhate contents compared with those who are unintentionally exposed. In comparison with unexposed adolescents, reporting other risky experiences was a risk factor for both types of exposure. Furthermore, NBA worked differently-reactive NBA was a risk factor for intentional exposure, but proactive NBA did not play a role and even decreased the chance of unintentional exposure. Digital skills increased both types of exposure. Our findings stress the need to differentiate between intentional and unintentional cyberhate exposure and to examine proactive and reactive NBA separately.
Raná intervence, jako podpora rodiny dítěte se zdravotním postižením v jeho raném věku, je pro život rodiny a daného dítěte klíčová. Obraz jedince se zdravotním postižením je komplikovaný – čím komplikovanější je, tím více zpravidla vyžaduje interdisciplinární, respektive transdisciplinární přístup – intervenci profesionálů z mnoha oborů (medicína, psychologie, speciální pedagogika, sociální služby a další). Uvedený text předkládá výsledky studie zabývající se fungováním rané intervence v České republice a ve Finsku a jejím srovnáním, a to konkrétně v tématu mezioborové spolupráce. Výzkum byl proveden ve čtyřech zařízeních rané péče v Česku a ve třech zařízeních rané intervence ve Finsku pomocí dotazníků a jejich následnou kvalitativní analýzou. Text předkládá výsledky a doporučení.
As a form of support for a family of a child with a disability at an early age, early intervention is key for the life of the family and the child. The state of the individual with a disability is complicated - the more complicated it is, the more it generally requires an interdisciplinary, or rather transdisciplinary approach - the intervention of professionals from many fields (medicine, psychology, special education, social services, and others). This text presents the results of the research dealing with the functioning of early intervention in the Czech Republic and Finland and its comparison, specifically on the topic of interdisciplinary cooperation. The research was conducted in four facilities of early intervention in the Czech Republic and three in Finland using a questionnaire and subsequent qualitative analysis. The text presents results and recommendations.
- MeSH
- dítě MeSH
- lidé MeSH
- mezioborová komunikace * MeSH
- postižené děti MeSH
- průzkumy a dotazníky MeSH
- raná péče * metody MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Geografické názvy
- Česká republika MeSH
- Finsko MeSH
Survival studies are an important indicator of the success of cancer control. We analyzed the 5-year relative survival in 23 solid cancers in Denmark, Finland, Norway and Sweden over a 50-year period (1970-2019) at the NORDCAN database accessed from the International Agency for Research on Cancer website. We plotted survival curves in 5-year periods and showed 5-year periodic survival. The survival results were summarized in four groups: (1) cancers with historically good survival (>50% in 1970-1974) which include melanoma and breast, endometrial and thyroid cancers; (2) cancers which constantly improved survival at least 20% units over the 50 year period, including cancers of the stomach, colon, rectum, kidney, brain and ovary; (3) cancer with increase in survival >20% units with changes taking place in a narrow time window, including oral, oropharyngeal, testicular and prostate cancers; (4) the remaining cancers with <20% unit improvement in survival including lung, esophageal, liver, pancreatic, bladder, soft tissue, penile, cervical and vulvar cancers. For cancers in groups 1 and 2, the constant development implied multiple improvements in therapy, diagnosis and patient care. Cancers in group 3 included testicular cancers with known therapeutic improvements but for the others large incidence changes probably implied that cancer stage (prostate) or etiology (oropharynx) changed into a more tractable form. Group 4 cancers included those with dismal survival 50 years ago but a clear tendency upwards. In 17 cancers 5-year survival reached between 50% and 100% while in only six cancers it remained at below 50%.
- MeSH
- incidence MeSH
- lidé MeSH
- míra přežití MeSH
- nádory * MeSH
- registrace MeSH
- rizikové faktory MeSH
- testikulární nádory * MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Dánsko MeSH
- Finsko MeSH
- Skandinávie a severské státy MeSH
- Švédsko MeSH
